Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysisBMJ (Online), 2022-03, Vol.376, p.e068632-e068632 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2022 BMJ ;ISSN: 1756-1833 ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj-2021-068632 ;PMID: 35236664Full text available |
|
2 |
Material Type: Article
|
Response to SARS-CoV-2 vaccination in patients after hematopoietic cell transplantation and CAR T-cell therapyBlood, 2021-10, Vol.138 (14), p.1278-1281 [Peer Reviewed Journal]2021 American Society of Hematology ;2021 by The American Society of Hematology 2021 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2021012769 ;PMID: 34339501Full text available |
|
3 |
Material Type: Article
|
Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunityCell, 2021-04, Vol.184 (9), p.2372-2383.e9 [Peer Reviewed Journal]2021 Elsevier Inc. ;Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved. ;2021 The Author(s) 2021 ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2021.03.013 ;PMID: 33743213Full text available |
|
4 |
Material Type: Article
|
Viral targets for vaccines against COVID-19Nature reviews. Immunology, 2021-02, Vol.21 (2), p.73-82 [Peer Reviewed Journal]COPYRIGHT 2021 Nature Publishing Group ;Springer Nature Limited 2020. ;Springer Nature Limited 2020 ;ISSN: 1474-1733 ;EISSN: 1474-1741 ;DOI: 10.1038/s41577-020-00480-0 ;PMID: 33340022Full text available |
|
5 |
Material Type: Article
|
Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19New England Journal of Medicine, 2021-06, Vol.384 (23), p.2259-2261 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMc2103916 ;PMID: 33822494Digital Resources/Online E-Resources |
|
6 |
Material Type: Article
|
New SARS-CoV-2 Variants — Clinical, Public Health, and Vaccine ImplicationsNew England Journal of Medicine, 2021-05, Vol.384 (19), p.1866-1868 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMc2100362 ;PMID: 33761203Digital Resources/Online E-Resources |
|
7 |
Material Type: Article
|
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) VariantNew England Journal of Medicine, 2021-08, Vol.385 (7), p.585-594 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2108891 ;PMID: 34289274Digital Resources/Online E-Resources |
|
8 |
Material Type: Article
|
COVID-19 vaccines: where we stand and challenges aheadCell death and differentiation, 2021-02, Vol.28 (2), p.626-639 [Peer Reviewed Journal]The Author(s), under exclusive licence to ADMC Associazione Differenziamento e Morte Cellulare 2021. ;The Author(s), under exclusive licence to ADMC Associazione Differenziamento e Morte Cellulare 2021 ;ISSN: 1350-9047 ;EISSN: 1476-5403 ;DOI: 10.1038/s41418-020-00720-9 ;PMID: 33479399Full text available |
|
9 |
Material Type: Article
|
Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccinationThe Lancet (British edition), 2021-06, Vol.397 (10292), p.2331-2333 [Peer Reviewed Journal]2021 Elsevier Ltd ;2021. Elsevier Ltd ;2021 Elsevier Ltd. All rights reserved. 2021 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)01290-3 ;PMID: 34090624Full text available |
|
10 |
Material Type: Article
|
Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited seraNature medicine, 2021-04, Vol.27 (4), p.620-621 [Peer Reviewed Journal]COPYRIGHT 2021 Nature Publishing Group ;The Author(s), under exclusive licence to Springer Nature America, Inc. part of Springer Nature 2021. ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/s41591-021-01270-4 ;PMID: 33558724Full text available |
|
11 |
Material Type: Article
|
SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasionNature (London), 2021-11, Vol.599 (7883), p.114-119 [Peer Reviewed Journal]2021. The Author(s). ;Copyright Nature Publishing Group Nov 4, 2021 ;The Author(s) 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-03944-y ;PMID: 34488225Full text available |
|
12 |
Material Type: Article
|
Third BNT162b2 Vaccination Neutralization of SARS-CoV-2 Omicron InfectionNew England Journal of Medicine, 2022-02, Vol.386 (5), p.492-494 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMc2119358 ;PMID: 34965337Digital Resources/Online E-Resources |
|
13 |
Material Type: Article
|
Adaptive immunity to SARS-CoV-2 and COVID-19Cell, 2021-02, Vol.184 (4), p.861-880 [Peer Reviewed Journal]2021 Elsevier Inc. ;Copyright © 2021 Elsevier Inc. All rights reserved. ;COPYRIGHT 2021 Elsevier B.V. ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2021 Elsevier Inc. 2021 Elsevier Inc. ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2021.01.007 ;PMID: 33497610Digital Resources/Online E-Resources |
|
14 |
Material Type: Article
|
Plasma Neutralization of the SARS-CoV-2 Omicron VariantNew England Journal of Medicine, 2022-02, Vol.386 (6), p.599-601 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMc2119641 ;PMID: 35030645Digital Resources/Online E-Resources |
|
15 |
Material Type: Article
|
SARS-CoV-2 Omicron Variant Neutralization in Serum from Vaccinated and Convalescent PersonsNew England Journal of Medicine, 2022-02, Vol.386 (7), p.698-700 [Peer Reviewed Journal]Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;2022. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2022 Massachusetts Medical Society. All rights reserved. 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMc2119236 ;PMID: 35021005Digital Resources/Online E-Resources |
|
16 |
Material Type: Article
|
Antibody Response to COVID-19 Vaccination in Patients Receiving DialysisJournal of the American Society of Nephrology, 2021-10, Vol.32 (10), p.2435-2438 [Peer Reviewed Journal]Copyright © 2021 by the American Society of Nephrology 2021 ;ISSN: 1046-6673 ;EISSN: 1533-3450 ;DOI: 10.1681/asn.2021050611 ;PMID: 34117129Full text available |
|
17 |
Material Type: Article
|
Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralizationCell host & microbe, 2021-05, Vol.29 (5), p.747-751.e4 [Peer Reviewed Journal]2021 Elsevier Inc. ;Copyright © 2021 Elsevier Inc. All rights reserved. ;2021 Elsevier Inc. 2021 Elsevier Inc. ;ISSN: 1931-3128 ;EISSN: 1934-6069 ;DOI: 10.1016/j.chom.2021.04.007 ;PMID: 33887205Full text available |
|
18 |
Material Type: Article
|
Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escapeNature reviews. Immunology, 2021-10, Vol.21 (10), p.626-636 [Peer Reviewed Journal]2021. Springer Nature Limited. ;COPYRIGHT 2021 Nature Publishing Group ;Springer Nature Limited 2021. ;Springer Nature Limited 2021 ;ISSN: 1474-1733 ;EISSN: 1474-1741 ;DOI: 10.1038/s41577-021-00592-1 ;PMID: 34373623Full text available |
|
19 |
Material Type: Article
|
Myocarditis With COVID-19 mRNA VaccinesCirculation (New York, N.Y.), 2021-08, Vol.144 (6), p.471-484 [Peer Reviewed Journal]2021 American Heart Association, Inc. 2021 ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.121.056135 ;PMID: 34281357Full text available |
|
20 |
Material Type: Article
|
Durability of Responses after SARS-CoV-2 mRNA-1273 VaccinationThe New England journal of medicine, 2021-01, Vol.384 (1), p.80-82 [Peer Reviewed Journal]Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. All rights reserved. 2020 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMc2032195 ;PMID: 33270381Full text available |